Aqvesme Tablet, Film Coated
Product Images NDC 71334-235

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aqvesme (NDC 71334-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Agios Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Aqvesme 1)

Chemical Structure (Aqvesme 1)
Chemical structure diagram showing a molecule with a piperidine ring connected to a sulfonamide group attached to two aromatic rings. The image includes a hydrate annotation indicating the structure is associated with sulfuric acid and water molecules (.H2SO4ยท3H2O) in a 2:1 ratio. This represents the chemical structure of mitapivat.*
FDA Label Image

Figure 1 (Aqvesme 2)

Figure 1 (Aqvesme 2)
This figure shows a bar chart comparing the average change from baseline in Hb concentration between AQVESME (mitapivat) and placebo groups. The y-axis represents change in Hb concentration from week 12 through 24. Data points are presented separately for AQVESME (N=130) and placebo (N=64) with additional annotations for Hb category and thalassemia genotype status.*
FDA Label Image

Figure 2 (Aqvesme 3)

Figure 2 (Aqvesme 3)
A line graph comparing the LS mean (95% CI) of change from baseline in hemoglobin (g/dL) over 24 weeks between AQVESME and placebo groups. The x-axis shows weeks from baseline to week 24, and the y-axis displays the change in hemoglobin levels. AQVESME shows a positive increase over time, while placebo remains near baseline with minor fluctuations.*
FDA Label Image

Carton 100 mg (Aqvesme 4)

Carton 100 mg (Aqvesme 4)
Packaging label for Aqvesme (mitapivat) tablets, 100 mg per tablet. The label shows 56 film-coated oral tablets in blister wallets, manufactured by Agios Pharmaceuticals, Inc. It includes storage instructions and the NDC 71334-235. The carton displays the product name, dosage form, strength, and manufacturer details along with a tablet image marked 'M 100'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.